Shijiazhuang Pingan Hospital
Shijiazhuang, Hebei, 050021, China
NCT Number: NCT05563207
To explore the effect of traditional Chinese medicine (TCM) health education standard path on the treatment of patients with acute myeloid leukemia (AML). A total of 60 patients with acute myeloid leukemia in Shijiazhuang Ping An Hospital were selected and divided into control group (n=30) and observation group (n=30) according to the time of admission. Both groups received the same chemotherapy, the control group received routine nursing, and the observation group received TCM health education standard path intervention. The scores of Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), Spitzer Quality of Life Index (QLI), awareness of TCM health education standard path content and nursing satisfaction were compared between the two groups.
Looking for future studies?
Notify Me37 year–68 year
All sexes
Interventional
Not applicable
Shijiazhuang, Hebei, 050021, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Both groups of patients were given routine treatment, and were intervened by the same batch of nursing staff.During chemotherapy, the patient's condition was closely observed, patiently listened to the patient's chief complaint, answered their questions, and instructed the patient to follow the doctor's instructions to prevent complications such as infection and bleeding.
When the patient was admitted to the hospital, the responsible nurse had a comprehensive understanding of the patient's disease cognition and psychological state, and based on this, an individualized intervention plan was formulated. With the help of publicity boards, brochures and other forms of pictures and texts, to popularize the knowledge and precautions of disease treatment for patients
adopt one-to-one method to inform patients of the principles, effects and precautions of chemotherapy, eliminate patients' misunderstandings, and repeat language education for many times during the treatment process to strengthen patients' memory
guide patients to express their own emotions, according to the patient's personality, cultural background, etc., after communicating with family members and negotiating, selectively inform the patient's actual condition
instruct patients to follow the principles of light, easy to digest and balanced nutrition
Actively inform patients about complications in advance, and guide their prevention methods, such as increasing water intake, avoiding activities of affected limbs after chemotherapy, etc. Patients with vomiting, hair loss and other adverse reactions are prone to negative emotions such as anxiety and depression , timely take corresponding measures and appease the patient, inform them that it is a normal phenomenon, and guide them to maintain a good attitude.
Time frame: 3 months of intervention
evaluate the anxiety of the two groups of patients before and after intervention
Time frame: 3 months of intervention
evaluate depression of the two groups of patients before and after intervention
Time frame: 3 months of intervention
the Spitzer Quality of Life Index (QLI) was used to evaluate the quality of life of patients
Time frame: 3 months of intervention
5 items of propaganda and education content, propaganda and education form, professional level of propaganda and education, nurses' professional attitude, and propaganda and education effect
Time frame: 3 months of intervention
evaluate the nursing attitude, nursing skills, and explanations of medical staff
Shijiazhuang Pingan Hospital
Other
Shijiazhuang Pingan Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03836209
Acute Myeloid Leukemia, Hematologic Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT03374332
Acute Myeloid Leukemia, Disease Attributes
Providence, Rhode Island, United States
View Trial DetailsNCT03455504
Acute Myeloid Leukemia, Hematologic Diseases
Bergamo, Italy
View Trial DetailsNCT03480360
Acute Myeloid Leukemia, Anemia
Lebanon, New Hampshire, United States
View Trial Details